A New Milestone for Rare Disease Treatment The U.S. Food and Drug Administration (FDA) has approved FAYUVI (rebisufligene etisparvovec-hopf), developed by Ultragenyx Pharmaceutical, for pediatric…
The pharmaceutical industry is entering a period in which regulatory strategy may increasingly influence not only compliance but also the speed and economics of innovation.…
Biotechnology has traditionally been evaluated through the lens of individual products: a novel therapy, a breakthrough diagnostic, a proprietary enzyme, or a differentiated biological ingredient.…
Introduction Hair smoothing and straightening treatments have become a staple in the beauty and personal care industry, promising sleek, frizz-free, and manageable hair for months.…
Introduction Hair smoothing and straightening treatments have become a staple in the beauty and personal care industry, promising sleek, frizz-free, and manageable hair for months.…
The global beauty and personal care industry continues to evolve at a rapid pace, driven by scientific innovation, shifting consumer expectations, and regulatory advancements. At…
Food safety is no longer just a regulatory requirement—it is a critical pillar of public health, global trade, and consumer trust. In an increasingly interconnected…
The recent approval of the first non-antipsychotic drug for treating agitation associated with dementia marks a pivotal shift in the neuropsychiatric and geriatric care landscape.…
The upcoming fiscal third-quarter earnings webcast by The Estée Lauder Companies Inc. on May 1, 2026, is more than a routine financial disclosure—it represents a…